Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye‐drops among rats, rabbits and monkeys-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye‐drops among rats, rabbits and monkeys

Published:2019-11-20 Issue:6 Volume:7 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Horita Shinya¹²^ORCID,Watanabe Miwa¹,Katagiri Mai¹,Nakamura Hiroaki¹,Haniuda Hiroki³,Nakazato Tomoyuki³,Kagawa Yoshiyuki²

Affiliation:

1. R&D Division Kyowa Kirin Co., Ltd. Sunto‐gun Shizuoka Japan

2. Department of Clinical Pharmaceutics School of Pharmaceutical Sciences University of Shizuoka Sunto‐gun Shizuoka Japan

3. Production Division Kyowa Kirin Co., Ltd. Sunto‐gun Shizuoka Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.545

Reference39 articles.

1. Prevalence of Age-Related Macular Degeneration in the United States

2. 2002 Global update of available data on visual impairment: a compilation of population-based prevalence studies

3. Age-related macular degeneration

4. Neovascular Age-Related Macular Degeneration

5. The Prevalence of Age-Related Macular Degeneration in Asians

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QbD-Based Development and Evaluation of Pazopanib Hydrochloride Extrudates Prepared by Hot-Melt Extrusion Technique: In Vitro and In Vivo Evaluation;Pharmaceutics;2024-06-04

2. Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration;Cells;2024-03-20

3. Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species;Pharmaceuticals;2024-01-13

4. Multicompartmental pharmacokinetic evaluation of enavogliflozin eye drop formulation: Understanding its distribution to posterior segments;Journal of Pharmaceutical Investigation;2024-01-08

5. OCULAR INSERETS AS A MODERN THERAPY TREND IN OPTHALMOPATHOLOGY;International Journal of Applied Pharmaceutics;2023-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3